TAK
Takeda Pharmaceutical Company
DRUG MANUFACTURERS - SPECIALTY & GENERIC · HEALTHCARE
Takeda Pharmaceutical Company Limited (Ticker: TAK) is a prominent global biopharmaceutical firm based in Tokyo, Japan, that focuses on delivering innovative therapeutic solutions primarily in oncology, gastroenterology, and neuroscience. With a strong commitment to research and development, Takeda ...
$17.10
-0.90% ($0.16)
Volume
4.11M
52W High
$18.90
52W Low
$12.99
Market Cap
$56.68B
Next Earnings Report
Last Reported
Jul 30, 2026 Beat
Actual: $0.52
vs. Consensus: $0.41
Price Chart
EPS History: Consensus vs Actual
Last 10 quartersPrice Movement Around Earnings
Q2 2026
Jul 30, 2026
1-Day:
-0.93%
Q1 2026
May 13, 2026
1-Day:
-0.06%
5-Day:
-0.42%
Q4 2025
Jan 29, 2026
1-Day:
+0.35%
5-Day:
+1.51%
Q3 2025
Oct 30, 2025
1-Day:
+1.59%
5-Day:
+2.49%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q1'26 | $1.11T | +5.8% | 48.8% | 4.3% | -$24.77B |
| Q4'25 | $1.21T | +6.0% | 54.4% | 16.0% | $105.51B |
| Q3'25 | $1.11T | -5.4% | 65.9% | 6.2% | -$11.80B |
| Q2'25 | $1.11T | -8.4% | 65.2% | 16.7% | $124.24B |
| Q1'25 | $1.05T | +0.2% | 63.7% | -7.1% | -$103.20B |
| Q4'24 | $1.14T | +3.0% | 63.6% | 5.9% | $23.79B |
| Q3'24 | $1.18T | +12.8% | 66.5% | 15.7% | $92.05B |
| Q2'24 | $1.21T | +14.1% | 68.0% | 13.8% | $95.25B |
Company Information
Symbol
TAK
Company
Takeda Pharmaceutical Company
Market Cap
$56.68B
Sector
HEALTHCARE
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - SPECIALTY & GENERIC
Compare TAK with competitors
Side-by-side earnings comparison